Avinash G. Dinmohamed
- Hematology top 5%
- Acute Myeloid Leukemia Research 21
- Chronic Myeloid Leukemia Treatments 8
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 13
- Myeloproliferative Neoplasms: Diagnosis and Treatment 9
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 29
-
- Viral-associated cancers and disorders 10
-
- Acute Lymphoblastic Leukemia research 15
-
- CNS Lymphoma Diagnosis and Treatment 8
- Co-authors
- Otto VisserMojca Jongen‐LavrencicPieter SonneveldArjan A. van de LoosdrechtPeter C. HuijgensEduardus F. M. PosthumaYvette van NordenJan J. Cornelissen
- Partner nations
- NetherlandsUnited StatesFrance
In The Last Decade
Avinash G. Dinmohamed
55 papers receiving 627 citations
Peers
Comparison fields: 5 of 72
- Hematology 274
- Genetics 203
- Pathology and Forensic Medicine 156
- Oncology 221
- Public Health, Environmental and Occupational Health 127
Countries citing papers authored by Avinash G. Dinmohamed
This map shows the geographic impact of Avinash G. Dinmohamed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avinash G. Dinmohamed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avinash G. Dinmohamed more than expected).
Fields of papers citing papers by Avinash G. Dinmohamed
This network shows the impact of papers produced by Avinash G. Dinmohamed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avinash G. Dinmohamed. The network helps show where Avinash G. Dinmohamed may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Avinash G. Dinmohamed, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 38 | |
| 7 | 2023 | 0 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 11 | |
| 10 | 2022 | 1 | |
| 11 | 2021 | 2 | |
| 12 | 2021 | 14 | |
| 13 | 2021 | 3 | |
| 14 | 2021 | 0 | |
| 15 | 2021 | 1 | |
| 16 | 2020 | 5 | |
| 17 | 2019 | 1 | |
| 18 | 2018 | 4 | |
| 19 | 2017 | 3 | |
| 20 | 2014 | 41 |
About Avinash G. Dinmohamed
Avinash G. Dinmohamed is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 62 papers that have together received 633 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (29 papers), Acute Myeloid Leukemia Research (21 papers), Acute Lymphoblastic Leukemia research (15 papers), Chronic Lymphocytic Leukemia Research (13 papers), Viral-associated cancers and disorders (10 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers), CNS Lymphoma Diagnosis and Treatment (8 papers) and Chronic Myeloid Leukemia Treatments (8 papers). The work is most often cited by research in Hematology (274 citations), Genetics (203 citations) and Pathology and Forensic Medicine (156 citations). Avinash G. Dinmohamed has collaborated with scholars based in Netherlands, United States and France. Frequent co-authors include Otto Visser, Mojca Jongen‐Lavrencic, Pieter Sonneveld, Arjan A. van de Loosdrecht, Peter C. Huijgens, Eduardus F. M. Posthuma, Yvette van Norden, Jan J. Cornelissen, Gerwin Huls and Nicole M. A. Blijlevens. Their work appears in journals such as Leukemia, British Journal of Haematology, HemaSphere, Blood Cancer Journal and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.